Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor

NCT03069469 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Neoplasm
Pigmented Villonodular Synovitis
Giant Cell Tumor of Tendon Sheath
Tenosynovial Giant Cell Tumor
Tenosynovial Giant Cell Tumor, Diffuse

Interventions

DRUG: Vimseltinib

Sponsor

Deciphera Pharmaceuticals, LLC